Breaking News

Meet the guy who'll lead the federal study on vaccines and autism

March 27, 2025
theresa-g-avatar-small - light bg
Morning Rounds Writer and Podcast Producer

STAT reporters updated our exclusive Breakthrough Device Tracker today. Take a look at the updates — interestingly, most of the companies to receive the FDA's designation between December and mid-March are small startups getting this status for the first time.

And ICYMI: A nighttime scoop from Anil Oza on what Jay Bhattacharya prioritized on his first day leading the NIH.

politics

Meet the guy who'll lead the federal study on vaccines and autism 

You may not have heard of David Geier, but news that he was hired by HHS to conduct a federal study on immunizations and autism has been met with dropped jaws among vaccine experts, STAT's Helen Branswell reports. "My first thought was … is this a hoax?" British investigative journalist Brian Deer said to Helen.

Geier (who does not have a medical degree) and his father (who has the degree but, in multiple states, lost his license to practice) have long promoted claims that the use of the preservative thimerosal in vaccines led to an increase in autism diagnoses. There's stacks of studies refuting that allegation, and the fact that autism rates have not gone down in the two decades since it was phased out of most vaccines. Read more from Helen about Geier's resume and the concerns that experts have raised.


medicine

The power of a diverse surgical faculty

In general surgery training programs, higher percentages of female faculty are associated with lower dropout rates for all residents, with especially strong correlations for female residents and those from backgrounds underrepresented in medicine. Higher promotion rates for underrepresented faculty are also significantly linked to lower attrition rates for underrepresented trainees. That's all according to a study of more than 26,700 general surgical residents from 136 institutions published yesterday in JAMA Surgery.  

More specifically: Programs included in the study ranged from zero to 54% female faculty and from zero all the way to 100% underrepresented faculty. For every 10-percentage-point increase in female faculty, the odds of a female resident leaving before the end of their training decreased by 14%, and for underrepresented trainees, 16%. This is the first study to examine correlations between faculty diversity, promotion, and retention and attrition, the authors write. While a "more granular exploration" of underrepresented groups is needed, they add, the results demonstrate the importance of a diverse workforce.


science

First gene-edited pig liver transplanted into a brain-dead person 

In a medical first, a research team in China has successfully stitched a CRISPR gene-edited pig liver into a brain-dead patient and kept the organ alive and functioning for 10 days. 

Last year, researchers at the University of Pennsylvania showed that a  gene-edited pig's liver located outside the body could circulate the blood of a clinically dead person for three days. The new results, published Wednesday in Nature, offer important insights into whether pig-liver transplants might be able to keep people alive for longer periods of time.

Members of the surgical team told reporters that the pig liver successfully secreted bile and showed no signs of rejection over the course of the experiment. The organ, derived from miniature pigs bred by the company Clonorgan Biotechnology in Chengdu, China, contained six genetic changes modified using CRISPR/Cas9 technology.

Xenotransplantation research has undergone a global renaissance in the past few years. Several severely ill patients have received engineered pig organs in the U.S. through compassionate use, with mixed results. Earlier this month the FDA cleared United Therapeutics to begin the first clinical trial focused on finding out if kidneys from gene-edited pigs can provide a viable alternative for desperate transplant patients. — Megan Molteni



chronic disease

One guinea pig step closer to a vaccine for Lyme disease

A tiny, black-legged tick rests on a person's finger.

BERTRAND GUAY/AFP via Getty Images 

How do you solve a problem like a tick bite? As the tiny creature is sucking out a person's blood, it's also doling out proteins to keep that blood flowing, painlessly, while hampering any immune response. That's when it can pass along the bacteria that leads to Lyme disease and other conditions. 

But some people, along with other mammals like guinea pigs, can develop resistance to ticks after enough exposure. A new study, published yesterday in Science Translational Medicine, examined how the immune system reacts differently when that resistance is there. Read the story from STAT's Isabella Cueto for a detailed explanation of the science. But essentially: Researchers found that tick antigens were trying to suppress histamine, which triggers allergic reactions. Then, they used those antigens to create an mRNA vaccine for guinea pigs. It worked, but there's a lot more to be done before there's a vaccine for people. Read more.


one big number

2.9 million

That's the high end of an estimated range for how many additional HIV-related deaths could occur in low-and-middle income countries between 2025 and 2030 if the U.S. and other wealthy nations follow through with proposed international aid reductions. Five countries — the U.S., U.K., France, Germany, and the Netherlands — provide almost all international HIV funding. All of them have recently announced plans to significantly cut foreign aid.

Researchers conducted a modelling analysis, published yesterday in The Lancet HIV, which calculated there could be between 4.4 and 10.8 million additional HIV infections and between 770,000 and 2.9 million related deaths in low-and-middle-income countries by 2030.


first opinion

The repercussions of slashing the SAMHSA budget

About a year ago, the federal Substance Abuse and Mental Health Services Administration requested more than $8.1 billion for its 2025 budget. It was a substantial increase from the $7.5 billion they'd received less than two years before. But the country is facing both a mental health crisis and an overdose epidemic. More than one in five people is estimated to experience mental illness, and suicide rates still haven't returned to pre-pandemic levels.

Under the Trump administration, SAMHSA faces massive cuts, with reports that its 900 employees could soon be reduced by half. In a new First Opinion essay, attorney and former public servant Patrick Wildes argues that the federal government needs to supplement SAMHSA's efforts, not undercut them. Read more about what the future of mental health could look like if SAMHSA shrinks.


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

What we're reading

  • Trump administration abruptly cuts billions from state health services, New York Times

  • Republicans' plan to cut government spending is hitting a major snag: Medicaid, STAT
  • Deadlifting in your nineties, in 'Strong Grandma,' New Yorker
  • It's time to block-grant Medicaid, STAT

Thanks for reading! More tomorrow,


Enjoying Morning Rounds? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2025, All Rights Reserved.

No comments